Indiana Administrative Code
Title 848 - INDIANA STATE BOARD OF NURSING
Article 5 - PRESCRIPTIVE AUTHORITY FOR ADVANCED PRACTICE NURSING
Rule 1 - Prescriptive Authority
Section 1-1 - Initial authority to prescribe legend drugs
Universal Citation: 848 IN Admin Code 1-1
Current through March 20, 2024
Authority: IC 25-23-1-7
Affected: IC 25-23-1
Sec. 1.
(a) An advanced practice nurse may be authorized to prescribe legend drugs, including controlled substances, if the advanced practice nurse does the following:
(1) Submits an application on a form
prescribed by the board with the required fee, including, but not limited to,
the following information:
(A) Complete name,
residence and office addresses with zip codes, and residence and business
telephone numbers with area codes.
(B) All names used by the applicant,
explaining the reasons for any name change or use.
(C) Date and place of birth.
(D) Citizenship and visa status, if
applicable.
(E) A complete
statement of all nursing education received, providing the following:
(i) Names and locations of all colleges,
schools, or universities attended.
(ii) Dates of attendance.
(iii) Degrees obtained or received.
(F) Whether the applicant has ever
had any disciplinary action taken against the applicant's nursing license by
the board or by the licensing agency of any other state or jurisdiction and the
details and dates thereof.
(G) A
complete list of all places of employment, including the following:
(i) The names and addresses of
employers.
(ii) The dates of each
employment.
(iii) Employment
responsibilities held or performed that the applicant had since graduation from
nursing school.
(H)
Whether the applicant is, or has been, addicted to any narcotic drug, alcohol,
or other drugs and, if so, the details thereof.
(I) Whether the applicant has been convicted
of any violation of law relating to drug abuse, controlled substances, narcotic
drugs, or any other drugs.
(J)
Whether the applicant has previously been licensed to practice nursing in any
other state or jurisdiction and, if so, the following:
(i) The names of such states or jurisdictions
that previously licensed the applicant.
(ii) The dates of such licensure.
(iii) The license number.
(iv) The current status of such
licensure.
(K) Whether
the applicant has been denied a license to practice nursing by any state or
jurisdiction and, if so, the details thereof, including the following:
(i) The name and location of the state or
jurisdiction denying licensure.
(ii) The date of denial of such
licensure.
(iii) The reasons
relating thereto.
(L) A
certified statement that the applicant has not been convicted of a criminal
offense (excluding minor traffic violations) or a certified statement listing
all criminal offenses of which the applicant has been convicted. This listing
must include the following:
(i) The offense of
which the applicant was convicted.
(ii) The court in which the applicant was
convicted.
(iii) The cause number
in which the applicant was convicted.
(M) All information in the application shall
be submitted under oath or affirmation, subject to the penalties for
perjury.
(2) Submits
proof of holding an active, unrestricted:
(A)
Indiana registered nurse license; or
(B) registered nurse license in another
compact state and having filed a Multi-state Privilege Notification Form with
the health professions bureau.
(3) Submits proof of having met the
requirements of all applicable laws for practice as an advanced practice nurse
in the state of Indiana.
(4)
Submits proof of a baccalaureate or higher degree in nursing.
(5) If the applicant holds a baccalaureate
degree only, submits proof of certification as a nurse practitioner or
certified nurse-midwife by a national organization recognized by the board and
which requires a national certifying examination.
(6) Submits proof of having successfully
completed a graduate level pharmacology course consisting of at least two (2)
semester hours of academic credit from a college or university accredited by
the Commission on Recognition of Postsecondary Accreditation:
(A) within five (5) years of the date of
application; or
(B) if the
pharmacology course was completed more than five (5) years immediately
preceding the date of filing the application, the applicant must submit proof
of the following:
(i) Completing at least
thirty (30) actual contact hours of continuing education during the two (2)
years immediately preceding the date of the application, including a minimum of
at least eight (8) actual contact hours of pharmacology, all of which must be
approved by a nationally approved sponsor of continuing education for
nurses.
(ii) Prescriptive
experience in another jurisdiction within the five (5) years immediately
preceding the date of the application.
(7) Submits proof of collaboration with a
licensed practitioner in the form of a written practice agreement that sets
forth the manner in which the advanced practice nurse and licensed practitioner
will cooperate, coordinate, and consult with each other in the provision of
health care to patients. Practice agreements shall be in writing and shall also
set forth provisions for the type of collaboration between the advanced
practice nurse and the licensed practitioner and the reasonable and timely
review by the licensed practitioner of the prescribing practices of the
advanced practice nurse. Specifically, the written practice agreement shall
contain at least the following information:
(A) Complete names, home and business
addresses, zip codes, and telephone numbers of the licensed practitioner and
the advanced practice nurse.
(B) A
list of all other offices or locations besides those listed in clause (A) where
the licensed practitioner authorized the advanced practice nurse to
prescribe.
(C) All specialty or
board certifications of the licensed practitioner and the advanced practice
nurse.
(D) The specific manner of
collaboration between the licensed practitioner and the advanced practice
nurse, including how the licensed practitioner and the advanced practice nurse
will:
(i) work together;
(ii) share practice trends and
responsibilities;
(iii) maintain
geographic proximity; and
(iv)
provide coverage during absence, incapacity, infirmity, or emergency by the
licensed practitioner.
(E) A description of what limitation, if any,
the licensed practitioner has placed on the advanced practice nurse's
prescriptive authority.
(F) A
description of the time and manner of the licensed practitioner's review of the
advanced practice nurse's prescribing practices. The description shall include
provisions that the advanced practice nurse must submit documentation of the
advanced practice nurse's prescribing practices to the licensed practitioner
within seven (7) days. Documentation of prescribing practices shall include,
but not be limited to, at least a five percent (5%) random sampling of the
charts and medications prescribed for patients.
(G) A list of all other written practice
agreements of the licensed practitioner and the advanced practice
nurse.
(H) The duration of the
written practice agreement between the licensed practitioner and the advanced
practice nurse.
(8)
Written practice agreements for advanced practice nurses applying for
prescriptive authority shall not be valid until prescriptive authority is
granted by the board.
(b) When the board determines that the applicant has met the requirements under subsection (a), the board shall send written notification of authority to prescribe to the advanced practice nurse, including the identification number and designated authorized initials to be used by the advanced practice nurse.
(c) Advanced practice nurses who have been granted prescriptive authority will immediately notify the board in writing of any changes in, or termination of, written practice agreements, including any changes in the prescriptive authority of the collaborating licensed practitioner. Written practice agreements shall terminate automatically if the advanced practice nurse or licensed practitioner no longer has an active, unrestricted license.
(d) Advanced practice nurses wishing to prescribe controlled substances must obtain an Indiana controlled substances registration and a federal Drug Enforcement Administration registration.
Disclaimer: These regulations may not be the most recent version. Indiana may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
